Welcome to
2. BIOTECH SUMMIT AUSTRIA
On October 10th and 11th, 2024, Innsbruck will become a hotspot for the Austrian and international biotech industry.
Biotech Austria, Human.technology Styria and the Standortagentur Tirol bring together the key players from the Austrian and international biotech industry and illuminate cutting-edge technology from different perspectives.
This year’s summit boasts an impressive lineup of keynote speakers who are set to inspire and enlighten attendees with their insights and experiences. Patrick Trojer, President & CEO of TRIANA Biomedicines, will share his visionary perspectives on the future of biomedicine. Joseph Pennninger and Gregor Wick, founders of Angios GmbH, will delve into groundbreaking developments in the biotech sphere. Isabella Gräf, along with Severin Schwan from Roche, will provide invaluable insights into the biotech industry's current landscape. Christoph Huber from BioNTech and Peter Llewellyn-Davies from BIOTECH AUSTRIA will highlight the synergies and innovations driving the sector forward. Don’t miss these influential leaders as they present thought-provoking keynotes that will set the tone for this year’s summit.
Topic Selection
- Trends and developments in biotechnology
- Funding & financing for start-ups and established companies
- How to exit - making real money from biotech
Keynotes and Impulse Speeches
- Patrick Trojer– President & CEO at TRIANA Biomedicines
- Joseph Pennninger & Gregor Wick, Founder Angios GmbH
- Isabella Gräf, CEO of Shenandoah Therapeutics
- Severin Schwan, Roche Holding
- Christoph Huber, BioNTech & Peter Llewellyn-Davies, BIOTECH AUSTRIA
Discussions & Panels with
- Guido Gualdoni, GST Antivirals
- Nicole Schlautmann, Pfizer Austria
- Doris Wilfllingseder, Medizinische Universität Innsbruck
- Ralf Huss, Bavarian Biotech Cluster Development BioM
- Andrea Pramböck, KPMG
- Ingrid Kelly Spillmann, XISTA
- Hubert Birner, TVM Capital
- Florian Schuster, Venga Ventures
- Matthias Kromayer, MIG Capital
- Rainer Strohmenger, Wellington Partners
- Nikolaus Krall, Allcyte - Exscientia
- Lisa Egerer, Vira Therapeutics - Boehringer Ingelheim
- Alexander Belcredi, PhagoMed - BioNTech
- and many more!
- Start-up-Corner & Start-up Pitches
- Networking
- 1:1-Partnering
Don’t Miss:
- Pre-Event & Socializing: Hike & Dine Umbrüggler Alm
- Dinner & Networking Party at Adlers Rooftop Bar
And:
Registration is open!
1. Biotech Summit in retrospect
The first Biotech Summit Austria - a milestone event for the Austrian and international biotechnology community - concluded on Friday in Graz, after two days of insightful discussions and networking. The event, co-hosted by BIOTECH AUSTRIA, the pioneering association for biotechnology in Austria, and the dynamic styrian cluster organization Human.technology Styria, left a lasting impression on the industry.
The summit exceeded expectations with more than 200 participants from ten countries, an array of enriching activities, including career sessions, startup pitches and extensive networking opportunities. The conference concluded on a high note with a gala dinner and celebration at a stunning event location embedded in a mountain situated below the castle in the heart of Graz.
f.l.t.r.: Peter Llewellyn-Davies (President BIOTECH AUSTRIA), Lejla
Pock (CEO Human.technology Styria), Barbara Eibinger-Miedl (Regional
Minister for Economy, Science and Research), Caroline Schober (Vice
Rector Research & International Affairs Medical University of Graz)
